[Alerte actualité] Anticorps XAV19
30 avril 2020 Download the press release / Télécharger le communiqué
More[Newsletter -1] NEWS / INFOS
May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
MoreIn the news / A la une
Journal des Entreprises – Coronavirus – XENOTHERA : « Nous prenons des risques entrepreneuriaux...
MoreCOVID19 / XAV19 : Scientific and medical rationale
Français ci-dessous « We are convinced that our treatment will be efficient, for...
More
XENOTHERA announces receivability of its Clinical Trial Application at the Czech Republic regulatory agency for a first in man clinical trial of LIS1 in kidney transplanted patients with dose escalation.
Nantes, June 21st, 2019 – XENOTHERA announces receivability after its submission of a Clinical...
More